326 related articles for article (PubMed ID: 21036237)
1. Constitutive activity of neural melanocortin receptors.
Tao YX; Huang H; Wang ZQ; Yang F; Williams JN; Nikiforovich GV
Methods Enzymol; 2010; 484():267-79. PubMed ID: 21036237
[TBL] [Abstract][Full Text] [Related]
2. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
[TBL] [Abstract][Full Text] [Related]
3. Biased signaling initiated by agouti-related peptide through human melanocortin-3 and -4 receptors.
Yang Z; Tao YX
Biochim Biophys Acta; 2016 Sep; 1862(9):1485-94. PubMed ID: 27208795
[TBL] [Abstract][Full Text] [Related]
4. Constitutive receptor activity series: endogenous inverse agonists and constitutive receptor activity in the melanocortin system.
Adan RA
Trends Pharmacol Sci; 2006 Apr; 27(4):183-6. PubMed ID: 16500715
[TBL] [Abstract][Full Text] [Related]
5. Chimeras of the agouti-related protein: insights into agonist and antagonist selectivity of melanocortin receptors.
Jackson PJ; Yu B; Hunrichs B; Thompson DA; Chai B; Gantz I; Millhauser GL
Peptides; 2005 Oct; 26(10):1978-87. PubMed ID: 16009463
[TBL] [Abstract][Full Text] [Related]
6. The interaction of MC3R and MC4R with MRAP2, ACTH, α-MSH and AgRP in chickens.
Zhang J; Li X; Zhou Y; Cui L; Li J; Wu C; Wan Y; Li J; Wang Y
J Endocrinol; 2017 Aug; 234(2):155-174. PubMed ID: 28512117
[TBL] [Abstract][Full Text] [Related]
7. The early origin of melanocortin receptors, agouti-related peptide, agouti signalling peptide, and melanocortin receptor-accessory proteins, with emphasis on pufferfishes, elephant shark, lampreys, and amphioxus.
Västermark A; Schiöth HB
Eur J Pharmacol; 2011 Jun; 660(1):61-9. PubMed ID: 21208605
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterization of 40 human melanocortin-4 receptor polymorphisms with the endogenous proopiomelanocortin-derived agonists and the agouti-related protein (AGRP) antagonist.
Xiang Z; Litherland SA; Sorensen NB; Proneth B; Wood MS; Shaw AM; Millard WJ; Haskell-Luevano C
Biochemistry; 2006 Jun; 45(23):7277-88. PubMed ID: 16752916
[TBL] [Abstract][Full Text] [Related]
9. The 1,4-benzodiazepine-2,5-dione small molecule template results in melanocortin receptor agonists with nanomolar potencies.
Joseph CG; Wilson KR; Wood MS; Sorenson NB; Phan DV; Xiang Z; Witek RM; Haskell-Luevano C
J Med Chem; 2008 Mar; 51(5):1423-31. PubMed ID: 18271518
[TBL] [Abstract][Full Text] [Related]
10. Neural melanocortin receptors are differentially expressed and regulated by stress in rat hypothalamic-pituitary-adrenal axis.
Wachira SJ; Hughes-Darden CA; Nicholas HB; Taylor CV; Robinson TJ
Cell Mol Biol (Noisy-le-grand); 2004 Sep; 50(6):703-13. PubMed ID: 15641161
[TBL] [Abstract][Full Text] [Related]
11. The melanocortin system in Fugu: determination of POMC/AGRP/MCR gene repertoire and synteny, as well as pharmacology and anatomical distribution of the MCRs.
Klovins J; Haitina T; Fridmanis D; Kilianova Z; Kapa I; Fredriksson R; Gallo-Payet N; Schiöth HB
Mol Biol Evol; 2004 Mar; 21(3):563-79. PubMed ID: 14694081
[TBL] [Abstract][Full Text] [Related]
12. Current trends in the structure-activity relationship studies of the endogenous agouti-related protein (AGRP) melanocortin receptor antagonist.
Wilczynski AM; Joseph CG; Haskell-Luevano C
Med Res Rev; 2005 Sep; 25(5):545-56. PubMed ID: 16044415
[TBL] [Abstract][Full Text] [Related]
13. Molecular basis of melanocortin-4 receptor for AGRP inverse agonism.
Chen M; Celik A; Georgeson KE; Harmon CM; Yang Y
Regul Pept; 2006 Sep; 136(1-3):40-9. PubMed ID: 16820227
[TBL] [Abstract][Full Text] [Related]
14. Stereochemical studies of the monocyclic agouti-related protein (103-122) Arg-Phe-Phe residues: conversion of a melanocortin-4 receptor antagonist into an agonist and results in the discovery of a potent and selective melanocortin-1 agonist.
Joseph CG; Wang XS; Scott JW; Bauzo RM; Xiang Z; Richards NG; Haskell-Luevano C
J Med Chem; 2004 Dec; 47(27):6702-10. PubMed ID: 15615519
[TBL] [Abstract][Full Text] [Related]
15. The natural inverse agonist agouti-related protein induces arrestin-mediated endocytosis of melanocortin-3 and -4 receptors.
Breit A; Wolff K; Kalwa H; Jarry H; Büch T; Gudermann T
J Biol Chem; 2006 Dec; 281(49):37447-56. PubMed ID: 17041250
[TBL] [Abstract][Full Text] [Related]
16. Discovery of Molecular Interactions of the Human Melanocortin-4 Receptor (hMC4R) Asp189 (D189) Amino Acid with the Endogenous G-Protein-Coupled Receptor (GPCR) Antagonist Agouti-Related Protein (AGRP) Provides Insights to AGRP's Inverse Agonist Pharmacology at the hMC4R.
Ericson MD; Haslach EM; Schnell SM; Freeman KT; Xiang ZM; Portillo FP; Speth R; Litherland SA; Haskell-Luevano C
ACS Chem Neurosci; 2021 Feb; 12(3):542-556. PubMed ID: 33470098
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms of the neural melanocortin receptor dysfunction in severe early onset obesity.
Tao YX
Mol Cell Endocrinol; 2005 Jul; 239(1-2):1-14. PubMed ID: 15975705
[TBL] [Abstract][Full Text] [Related]
18. Receptor-antagonist interactions in the complexes of agouti and agouti-related protein with human melanocortin 1 and 4 receptors.
Chai BX; Pogozheva ID; Lai YM; Li JY; Neubig RR; Mosberg HI; Gantz I
Biochemistry; 2005 Mar; 44(9):3418-31. PubMed ID: 15736952
[TBL] [Abstract][Full Text] [Related]
19. Structure-Activity Relationship Studies on a Macrocyclic Agouti-Related Protein (AGRP) Scaffold Reveal Agouti Signaling Protein (ASP) Residue Substitutions Maintain Melanocortin-4 Receptor Antagonist Potency and Result in Inverse Agonist Pharmacology at the Melanocortin-5 Receptor.
Ericson MD; Freeman KT; Schnell SM; Fleming KA; Haskell-Luevano C
J Med Chem; 2017 Oct; 60(19):8103-8114. PubMed ID: 28813605
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanism of the constitutive activation of the L250Q human melanocortin-4 receptor polymorphism.
Proneth B; Xiang Z; Pogozheva ID; Litherland SA; Gorbatyuk OS; Shaw AM; Millard WJ; Mosberg HI; Haskell-Luevano C
Chem Biol Drug Des; 2006 Mar; 67(3):215-29. PubMed ID: 16611215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
